You are subscribed to the Drug Topics Issue Alert.

Drug Topics Issue Alert eNewsletter Subscribe
Print/Digital Edition Subscribe

May 14, 2016

To view this email as a web page, click here  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

CHECK OUT OUR LATEST ISSUE

Telepharmacy unites the team

And it's not just in the hospital setting that telehealth and telepharmacy are making an impact. » More

Blog: The future of pharmacy is finally here

The subject today is what pharmacy's "big thinkers" have told us we'd soon not be doing — counting, pouring, licking, and sticking. » More

An overview of treatment options for constipation

The goal of this program is to assist pharmacists and pharmacy technicians in their understanding of the role of linaclotide, lubiprostone, methylnaltrexone, and naloxegol in the treatment of constipation. » More

Related Articles

The antisubstitution controversy: Going strong in '72

'I love my job,' says UCSF expert in HIV/AIDS, HCV

Walgreens, Qualcomm, United Healthcare partner through data exchange

 

Downloads

Drug Topics App - Download

Drug Topics Digital Edition - Download

You are subscribed to the Drug Topics Issue Alert.

 

Click to contact the editorial team. Click to contact the sales team.

Part of the

ModernMedicine logo

This email was sent by: %%Member_Busname%%
%%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%

 

NEWSLETTER

Forward to a Friend
Privacy Statement
Terms of Service
Update Profile
Add/Remove Newsletters
Contact Us